Amneal Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $0 | $0 |
| Depreciation & Amortization | — | — |
| Depreciation | $42.0M | $29.3M |
| Amortization | $73.0M | $3.7M |
| Stock-Based Compensation | $0 | $0 |
| Net Cash from Operating Activities | $234.2M | $115.1M |
| Investing Activities | ||
| Capital Expenditures | $94.8M | $122.8M |
| Business Acquisitions | $0 | $0 |
| Net Cash from Investing Activities | $-98.6M | $-124.6M |
| Financing Activities | ||
| Dividends Paid | $375.3M | $200.6M |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $-95.0M | $-19.5M |
| Net Change in Cash | $40.4M | $-27.6M |
| Free Cash Flow | $139.4M | $-7.7M |